Semaglutide and the Retina by Zachary T. Bloomgarden

Subjects: Get full text

One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists by Hirotaka Watada

Subjects: Get full text

Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment by Se-Eun Kim, Byung-Su Yoo

Subjects: Get full text

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medic... by Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa Sannidhi, Fatima Cody Stanford, Emily A. Callahan

Subjects: Get full text

Population profile and glycemic control following initiation or switch of injectable therapies in Tianjin, China: A real‐world retrospective cohort study of adults with type 2 diab... by Qiumei Zhang, Yaqing Fan, Xixi Liu, Minlu Zhang, Jiewen Zhang, Qin Du, Lei Kang, Liming Chen

Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text

Promising areas of pharmacotherapy for obesity by M. A. Druzhilov, T. Yu. Kuznetsova, G. A. Chumakova

Subjects: Get full text

Characterization of treatment intensified (add‐on to metformin) adults with type 2 diabetes in Thailand: A cross‐sectional real‐world study (CONVERGE) by Chutintorn Sriphrapradang, Ammarin Thakkinstian, Ratiporn Chinthammit, Gurudutt Nayak

Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text

Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes by Anna A Mosikian, Tatiana I Golikova, Mariia V Martjanova, Alina Y Babenko

Subjects: Get full text

Efficacy and Safety of Liraglutide in Adolescents Aged 12–15 Years with Obesity: a Prospective 24-week Observational by Olga P. Kovtun, Margarita A. Ustiuzhanina, Svyatoslav I. Solodushkin, Lyudmila V. Kovalchuk, Kira Ya. Zaslavskaya

Subjects: Get full text

Nephroprotective potential of glucagon-like peptide-1 receptor agonists by Minara S. Shamkhalova, Igor A. Sklyanik, Marina V. Shestakova

Subjects: Get full text

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database by Chao Tao, Chao Tao, Yinhui Zhang, Yinhui Zhang, Tenggang Wan, Wenting Zhao, Jing Chen, Ke Wang, Ke Wang, Liuxuan Yang, Guojun Wang, Qian Ding, Jinlu Shang, Meiling Zhou

Subjects: “…glucagon-like peptide-1 receptor agonists…”
Get full text

The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation by Alberto Sola‐Leyva, Amruta D. S. Pathare, Apostol Apostolov, Elina Aleksejeva, Keiu Kask, Triin Tammiste, Susana Ruiz‐Durán, Sanjiv Risal, Ganesh Acharya, Andres Salumets

Subjects: Get full text

Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact by Zhixuan Xie, Zhixuan Xie, Zhixuan Xie, Zuyi Yang, Zuyi Yang, Zuyi Yang, Dianzhe Tian, Youxin Chen, Youxin Chen

Subjects: “…glucagon-like peptide-1 receptor agonists…”
Get full text

A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait by Saleh Alali, Wed Al-Otaibi, Karen Ashodian, Nour Achour, Aishah Almulla, Hessa Mutlaq

Subjects: “…Glucagon-like peptide-1 receptor agonists…”
Get full text

Decreased incidence of hidradenitis suppurativa and psoriasis in diabetic patients treated with GLP-1 receptor agonists: A retrospective cohort study by Lauren M. Ching, BS, Christopher A. Guirguis, DMD, Nicholas L. Iskandar, Joe K. Tung, MD, MBA

Subjects: Get full text

Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction by Yan H, Yao W, Li Y, Li T, Song K, Yan P, Dang Y

Subjects: Get full text

Impact of Perioperative Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes Following Carpal Tunnel Release by Nicholas C. Bank, MD, Stephen J. Perle, BS, Bradley J. Lauck, BA, Alecia J. Rajesh, BS, Alexander D. Jeffs, MD, Reid W. Draeger, MD

Subjects: Get full text

Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective by Yosra Turkistani

Subjects: Get full text

Semaglutide in people with obesity and type 2 diabetes on hemodialysis: a prospective analysis of glycemic and weight outcomes by Akinori Hayashi, Ibuki Moriguchi, Naoyuki Kobayashi

Subjects: Get full text

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials by Yiwen Liu, Liyun He, Shumeng Han, Fan Ping, Wei Li, Lingling Xu, Huabing Zhang, Yuxiu Li

Subjects: Get full text